<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 29 Jul 2025 17:56:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  SCHEDULE 13G/A  Vincerx Pharma, Inc.                   Filed by: SAGE RHINO CAPITAL LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Vincerx+Pharma%2C+Inc.+++++++++++++++++++Filed+by%3A+SAGE+RHINO+CAPITAL+LLC/25115963.html</link>
   <description>si-local-file:///var/storage/secattach/20250729/25115963.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Vincerx+Pharma%2C+Inc.+++++++++++++++++++Filed+by%3A+SAGE+RHINO+CAPITAL+LLC/25115963.html</guid>
   <pubDate>Tue, 29 Jul 2025 17:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  Vincerx Pharma, Inc.                   Filed by: SAGE RHINO CAPITAL LLC</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Vincerx+Pharma%2C+Inc.+++++++++++++++++++Filed+by%3A+SAGE+RHINO+CAPITAL+LLC/25115963.html</link>
   <description>si-local-file:///var/storage/secattach/20250729/25115963.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Vincerx+Pharma%2C+Inc.+++++++++++++++++++Filed+by%3A+SAGE+RHINO+CAPITAL+LLC/25115963.html</guid>
   <pubDate>Tue, 29 Jul 2025 17:56:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25060219.html</link>
   <description>si-local-file:///var/storage/secattach/20250716/25060219.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25060219.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25060219.html</link>
   <description>si-local-file:///var/storage/secattach/20250716/25060219.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25060219.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Revised Potential Distribution Range of $0.03 to $0.07 per share&lt;br/&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;based on current estimates and assumptions&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;      &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal on a timely basis will result in continued operating &lt;br/&gt;costs and further reduce or eliminate any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;      &lt;p&gt;SAN MATEO, Calif., July  16, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Revised Potential Distribution Range of $0.03 to $0.07 per share&lt;br/&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;based on current estimates and assumptions&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;      &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal on a timely basis will result in continued operating &lt;br/&gt;costs and further reduce or eliminate any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;      &lt;p&gt;SAN MATEO, Calif., July  16, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Revised Potential Distribution Range of $0.03 to $0.07 per share&lt;br/&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;based on current estimates and assumptions&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;      &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal on a timely basis will result in continued operating &lt;br/&gt;costs and further reduce or eliminate any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;      &lt;p&gt;SAN MATEO, Calif., July  16, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Revised Potential Distribution Range of $0.03 to $0.07 per share&lt;br/&gt;&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;based on current estimates and assumptions&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;      &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal on a timely basis will result in continued operating &lt;br/&gt;costs and further reduce or eliminate any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;      &lt;p&gt;SAN MATEO, Calif., July  16, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today,</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Additional+Adjournment+of+Special+Meeting+-+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal/25060067.html</guid>
   <pubDate>Wed, 16 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25023310.html</link>
   <description>si-local-file:///var/storage/secattach/20250707/25023310.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25023310.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25023310.html</link>
   <description>si-local-file:///var/storage/secattach/20250707/25023310.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/25023310.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  8-K        Vincerx Pharma, Inc.      For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vincerx+Pharma%2C+Inc.++++++For%3A+Jun+30/25023273.html</link>
   <description>si-local-file:///var/storage/secattach/20250707/25023273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vincerx+Pharma%2C+Inc.++++++For%3A+Jun+30/25023273.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  8-K        Vincerx Pharma, Inc.      For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vincerx+Pharma%2C+Inc.++++++For%3A+Jun+30/25023273.html</link>
   <description>si-local-file:///var/storage/secattach/20250707/25023273.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Vincerx+Pharma%2C+Inc.++++++For%3A+Jun+30/25023273.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:23:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma urges stockholders to vote for dissolution proposal</title>
   <link>http://www.streetinsider.com/Corporate+News/Vincerx+Pharma+urges+stockholders+to+vote+for+dissolution+proposal/25022950.html</link>
   <description>&lt;p&gt;Vincerx Pharma Inc. (OTC Pink: VINC) announced Monday that it estimates potential distributions of $0.04 to $0.08 per share to stockholders if they approve the company's dissolution proposal at a special meeting scheduled for July 16.&lt;/p&gt;&lt;p&gt;The San Mateo, California-based company said the distribution range is based on current estimates and assumptions, including timely approval of the dissolution proposal. The company warned that delays in approving the proposal will result in continued operating costs and reduce or eliminate funds available for distribution to stockholders.&lt;/p&gt;&lt;p&gt;The special meeting will be held at 10:00 a.m. Pacific time via live audio webcast. Vincerx's board of</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Vincerx+Pharma+urges+stockholders+to+vote+for+dissolution+proposal/25022950.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:06:14 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal will reduce or eliminate &lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;  &lt;p&gt;SAN MATEO, Calif., July  07, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the “Special Meeting”) to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the “Dissolution Proposal”). The Special</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal will reduce or eliminate &lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;  &lt;p&gt;SAN MATEO, Calif., July  07, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the “Special Meeting”) to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the “Dissolution Proposal”). The Special</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal will reduce or eliminate &lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;  &lt;p&gt;SAN MATEO, Calif., July  07, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the “Special Meeting”) to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the “Dissolution Proposal”). The Special</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Potential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal&lt;/em&gt;&lt;/strong&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;strong&gt;&lt;em&gt;Failure to approve Dissolution Proposal will reduce or eliminate &lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;any potential distributions to stockholders&lt;/em&gt;&lt;/strong&gt;  &lt;/p&gt;  &lt;p&gt;SAN MATEO, Calif., July  07, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the “Special Meeting”) to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the “Dissolution Proposal”). The Special</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Urges+Stockholders+to+Vote+FOR+Approval+of+Dissolution+Proposal+and+Announces+Potential+Range+for+Distributions+to+Stockholders/25022909.html</guid>
   <pubDate>Mon, 07 Jul 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24953377.html</link>
   <description>si-local-file:///var/storage/secattach/20250618/24953377.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24953377.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24953377.html</link>
   <description>si-local-file:///var/storage/secattach/20250618/24953377.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24953377.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;SAN MATEO, Calif., June  18, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=uS2eHTSwuTa9i5fl96cmG87-b7U4Zc2URAoMcnjTXoZ2hm9Q0OJLcWgnPbuI0a8iLhUzd7Bfpwwbdqb3Hpq90RFxt20yK1Zy96rytmhP6ggdmOKt86ut0EwDDKJ-IV1uPGlqxmqN1yR1ZWNWWu6IZgBy-codx23lJwo_3TlaSTc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.virtualshareholdermeeting.com/VINC2025SM2&lt;/a&gt;. The adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Vincerx is urging ALL stockholders to vote IMMEDIATELY &lt;/strong&gt;&lt;strong&gt;FOR&lt;/strong&gt;&lt;strong&gt; the Dissolution Proposal.&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;SAN MATEO, Calif., June  18, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=uS2eHTSwuTa9i5fl96cmG87-b7U4Zc2URAoMcnjTXoZ2hm9Q0OJLcWgnPbuI0a8iLhUzd7Bfpwwbdqb3Hpq90RFxt20yK1Zy96rytmhP6ggdmOKt86ut0EwDDKJ-IV1uPGlqxmqN1yR1ZWNWWu6IZgBy-codx23lJwo_3TlaSTc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.virtualshareholdermeeting.com/VINC2025SM2&lt;/a&gt;. The adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Vincerx is urging ALL stockholders to vote IMMEDIATELY &lt;/strong&gt;&lt;strong&gt;FOR&lt;/strong&gt;&lt;strong&gt; the Dissolution Proposal.&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;SAN MATEO, Calif., June  18, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=uS2eHTSwuTa9i5fl96cmG87-b7U4Zc2URAoMcnjTXoZ2hm9Q0OJLcWgnPbuI0a8iLhUzd7Bfpwwbdqb3Hpq90RFxt20yK1Zy96rytmhP6ggdmOKt86ut0EwDDKJ-IV1uPGlqxmqN1yR1ZWNWWu6IZgBy-codx23lJwo_3TlaSTc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.virtualshareholdermeeting.com/VINC2025SM2&lt;/a&gt;. The adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Vincerx is urging ALL stockholders to vote IMMEDIATELY &lt;/strong&gt;&lt;strong&gt;FOR&lt;/strong&gt;&lt;strong&gt; the Dissolution Proposal.&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</link>
   <description>
&lt;p align=&quot;left&quot;&gt;SAN MATEO, Calif., June  18, 2025  (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC Pink: VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the “Dissolution Proposal”), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at &lt;a target=&quot;_blank&quot; href=&quot;https://www.globenewswire.com/Tracker?data=uS2eHTSwuTa9i5fl96cmG87-b7U4Zc2URAoMcnjTXoZ2hm9Q0OJLcWgnPbuI0a8iLhUzd7Bfpwwbdqb3Hpq90RFxt20yK1Zy96rytmhP6ggdmOKt86ut0EwDDKJ-IV1uPGlqxmqN1yR1ZWNWWu6IZgBy-codx23lJwo_3TlaSTc=&quot; rel=&quot;nofollow&quot; target=&quot;_blank&quot;&gt;www.virtualshareholdermeeting.com/VINC2025SM2&lt;/a&gt;. The adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal.&lt;/p&gt;  &lt;p&gt;&lt;strong&gt;Vincerx is urging ALL stockholders to vote IMMEDIATELY &lt;/strong&gt;&lt;strong&gt;FOR&lt;/strong&gt;&lt;strong&gt; the Dissolution Proposal.&lt;/strong&gt;&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Vincerx+Pharma%2C+Inc.+Announces+Adjournment+of+Special+Meeting+-+Will+Reconvene+Meeting+on+July+16%2C+2025+to+Secure+Votes+Needed+to+Approve+Dissolution+Proposal/24953001.html</guid>
   <pubDate>Wed, 18 Jun 2025 16:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24909002.html</link>
   <description>si-local-file:///var/storage/secattach/20250606/24909002.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24909002.html</guid>
   <pubDate>Fri, 06 Jun 2025 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
  <item>
   <title>Form  DEFA14A    Vincerx Pharma, Inc.                 </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24909002.html</link>
   <description>si-local-file:///var/storage/secattach/20250606/24909002.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++DEFA14A++++Vincerx+Pharma%2C+Inc.+++++++++++++++++/24909002.html</guid>
   <pubDate>Fri, 06 Jun 2025 16:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.48220458</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">VINC</category>
   	  </item>
 </channel>
</rss>
